DiaMedica Therapeutics (DMAC) Return on Equity [ROE] (2018 - 2026)
DiaMedica Therapeutics (DMAC) recorded Return on Equity [ROE] of -87.74% in Q2 2026, up 9.05 percentage points from -96.79% a year earlier but down 19.81 percentage points from the prior quarter.
Powered by 
Analysis
DiaMedica Therapeutics (DMAC) Return on Equity [ROE] (2018 - 2026) Analysis & Trends
For FY2025, DiaMedica Therapeutics reported Return on Equity [ROE] of -67.68%, down 14.41 percentage points from FY2024.
- Annual Return on Equity [ROE] has declined for three straight years, though with a five-year change of +5.42 percentage points (FY2020 to FY2025).
- Across earlier years, Return on Equity [ROE] came in at -53.27% in FY2024 (-6.50 pp), -46.77% in FY2023 (-10.71 pp), -36.06% in FY2022 (+2.75 pp) and -38.81% in FY2021 (+34.29 pp).
- Quarterly Return on Equity [ROE] has ranged from -96.79% in Q2 2025 to -29.85% in Q4 2021 over the past five years.
- On a year-over-year basis, Return on Equity [ROE] rose in two of the last eight quarters, with an average year-over-year change of -18.83 percentage points.
- Peak year-over-year performance for Return on Equity [ROE] in the last five years was a gain of 31.19 percentage points in Q2 2022, against a drop of 56.89 percentage points in Q2 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at -67.93% (Q1 2026), -60.83% (Q4 2025) and -81.04% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 25.32% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 7.21% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 84.40% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 21.39% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 83.75% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -18.38% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 4.97% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 22.24% |
| 10 | DiaMedica Therapeutics | 445.97 Mn | 445.97 Mn | - | -87.74% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -87.74% |
| Mar 31, 2026 | -67.93% |
| Dec 31, 2025 | -60.83% |
| Sep 30, 2025 | -81.04% |
| Jun 30, 2025 | -96.79% |
| Mar 31, 2025 | -72.32% |
| Dec 31, 2024 | -55.13% |
| Sep 30, 2024 | -42.82% |
| Jun 30, 2024 | -39.90% |
| Mar 31, 2024 | -39.55% |
| Dec 31, 2023 | -36.33% |
| Sep 30, 2023 | -31.15% |
| Jun 30, 2023 | -38.17% |
| Mar 31, 2023 | -52.47% |
| Dec 31, 2022 | -40.88% |
| Sep 30, 2022 | -36.19% |
| Jun 30, 2022 | -34.56% |
| Mar 31, 2022 | -31.79% |
| Dec 31, 2021 | -29.85% |
| Sep 30, 2021 | -43.19% |
API Access
DiaMedica Therapeutics Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=DMAC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "DMAC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=DMAC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();